loader
Please Wait
Applying Filters...

Quotient Sciences Quotient Sciences

X

Approved Drug Products containing 206321 listed in the FDA Orange Book. Original Data : FDA Website

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 NOVO (1)

filter

01 SOLUTION;SUBCUTANEOUS (1)

filter

01 RX (1)

filter

01 SAXENDA (1)

filter

01 Yes (1)

URL Supplier Web Content
SOLUTION; SUBCUTAN...
18MG/3ML (6MG/ML)
2014-12-23
206321
SAXENDA
RX
Yes
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for FDA Orange Book APPLICATION 206321

Looking for FDA Orange Book APPLICATION 206321 1

19

Novo Nordisk, based in Denmark, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is LIRAGLUTIDE RECOMBINANT, with a corresponding application number 206321.

Regulatory Information RX

With a dosage strength 18MG/3ML (6MG/ML)

Dosage Form Route SOLUTION; SUBCUTANEOUS

Reference Listed Drug Yes

Approved since 2014-12-23

Post Enquiry
POST ENQUIRY